Ecological model
We start with an ecological model of resident host-pathogen dynamics that assumes these populations are, respectively, genetically homogeneous. The ecological model underlies the evolutionary model we develop later. A complete description of the model, and the methods of analysis that follow, can be found in theSupplementary Information.
We consider a population of hosts classified according to their sex and disease status. At time t, there are Si=Si(t) sex-i individuals not infected by the pathogen, but susceptible to future infection (i=f for females, i=m for males). At time t there are also Ii=Ii(t) sex-i individuals who are not only infected with the pathogen but also able to transmit their infection to others. Our specific goal in this section is to develop a mathematical description of how the numbers of hosts in the various classes change over time.
The number of hosts in the population changes as a result of birth events. Following previous work44,45, we model the host mating rate using the harmonic mean of the population sizes of females and males. Assuming a one-to-one birth sex ratio, then newly born hosts of either sex join the population at rate (frac{b({S}_{f}+{I}_{f})({S}_{m}+{I}_{m})}{N}) where b>0, and N=N(t) denotes the total population size at time t. We assume that newborns produced by susceptible mothers are, themselves, susceptible. By contrast, we suppose that newborns produced by infected mothers acquire their mothers infection with probability v, where v is what we have called the vertical transmission rate31. Host number also changes because of death events. Hosts in every class experience natural mortality at per-capita rate N, where is a positive constant. Hosts infected by the pathogen also experience disease-related mortality at per-capita rate i (a measure of pathogen virulence) (Fig.7).
This model incorporates two sexes (females in red and males in blue) and vertical transmission (dashed line). The flow between compartments is represented by arrows and expressions next to each arrow represent the flow rate. Evolving phenotypes and drivers of their evolution are indicated in green and purple, respectively. Source data are provided as a Source Data file.
Numbers of hosts in any particular class changes as their disease-status changes. For example, we allow infected individuals to recover at per-capita rate i (a measure of host immunocompetence). We assume that, upon recovery, hosts move immediately into the appropriate susceptible group. In this way, we ignore the possibility that recovery implies immunity to subsequent infection. The disease status of hosts can also change because of horizontal disease-transmission events. We approach horizontal transmission in a standard way and assume that susceptible sex-i hosts acquire the pathogen horizontally from their infected sex-j counterparts at a total rate of SiijIj. Here, ij is a constant that reflects the transmissibility of the pathogen. We assume that when a host acquires an infection horizontally, it immediately becomes infectious (Fig.7).
The model described above is summarised mathematically using the following system of differential equations:
$$frac{d{S}_{f}}{dt}=frac{b({S}_{f}+(1-v){I}_{f})({S}_{m}+{I}_{m})}{N}+{gamma }_{f}{I}_{f}-{S}_{f}{beta }_{ff}{I}_{f}-{S}_{f}{beta }_{fm}{I}_{m}-mu N{S}_{f}$$
(1a)
$$frac{d{S}_{m}}{dt}=frac{b({S}_{f}+(1-v){I}_{f})({S}_{m}+{I}_{m})}{N}+{gamma }_{m}{I}_{m}-{S}_{m}{beta }_{mf}{I}_{f}-{S}_{m}{beta }_{mm}{I}_{m}-mu N{S}_{m}$$
(1b)
$$frac{d{I}_{f}}{dt}=frac{bv{I}_{f}({S}_{m}+{I}_{m})}{N}+{S}_{f}{beta }_{ff}{I}_{f}+{S}_{f}{beta }_{fm}{I}_{m}-({gamma }_{f}+{alpha }_{f}+mu N){I}_{f}$$
(1c)
$$frac{d{I}_{m}}{dt}=frac{bv{I}_{f}({S}_{m}+{I}_{m})}{N}+{S}_{m}{beta }_{mf}{I}_{f}+{S}_{m}{beta }_{mm}{I}_{m}-({gamma }_{m}+{alpha }_{m}+mu N){I}_{m}.$$
(1d)
Under a reasonable set of conditions, the previous system tends, over time, to an equilibrium state in which infections are endemic.
To study how pathogens disease-induced mortality and the hosts immune system respond to selection, we assume that each faces a life-history trade-off.
First, the pathogens ability to transmit horizontally trades off against the duration of any given infection it establishes. Following the previous authors30,46,47, we capture this trade-off by assuming
$${beta }_{ij}=beta ({alpha }_{j})=frac{{beta }_{max }{alpha }_{j}}{{alpha }_{j}+d}quad ,{{mbox{for}}},,j=f,;m,$$
(2)
where ({beta }_{max },,d , > , 0) are constants. Equation (2) implies that the nature of the trade-off faced by a pathogen is the same in both female and male hosts. Specifically, a pathogen can only increase its rate of horizontal transmission by increasing the disease-induced mortality rate experienced by its host (which, in turn, reduces the duration of infection). Equation (2) also says the horizontal transmission rate saturates at ({beta }_{max }) (independent of host sex), and does so more quickly as the parameter d is reduced (again, independent of host sex). Note also that Equation (2) does not depend on i: the sex of the susceptible host to whom the pathogen is transmitted.
For their part, hosts face a trade-off between investing resources in their immune system and their reproductive success. Increased immune investment is reflected in an increased recovery rate. To capture the hosts trade-off, then, we treat birth rate b as a decreasing function of the recovery rate. Moreover, we assume that the decrease in b is experienced by the host regardless of its disease status. In other words, we assume that cost associated with the immune system is an ongoing one, incurred mainly because of maintenance27 (this assumption model innate immunocompetence best) rather than being due to the activation that follows an infection48 (this assumption would model adaptive immunocompetence best). As noted in the Discussion, we relax this assumption in theSupplemental Material and compare the results for maintenance and activation costs. As an example, here, we point to evidence that shows female sex hormones enhance the immune system but simultaneously reduce the likelihood of conception and increase the chances of spontaneous abortion49,50,51. In mathematical terms, we capture the hosts trade-off using
$$b=b({gamma }_{f},{gamma }_{m})={b}_{max },{e}^{-{c}_{f}{gamma }_{f}^{2}},{e}^{-{c}_{m}{gamma }_{m}^{2}}$$
(3)
where ci reflects the rate at which fertility is reduced as sex-i immune function is increased (cost of recovery above). Equation (3) generalises the birth rate functions used previously27,48 to our sex-specific setting. The fact that b in this equation depends on both f and m reflects the fact that the reduced fertility of one mate affects the fertility of its partner16.
Our approach to modelling the co-evolution of host and pathogen is rooted in the adaptive-dynamics methodology52,53,54. For the pathogen population, we build a fitness expression that measures the success of a rare mutant strain in a population close to the endemic equilibrium established by the system (1) (indicated as ({bar{S}}_{i}), ({bar{I}}_{i}), and (bar{N})). Assuming that the mutant strain of pathogen is associated with a disease-induced mortality rate equal to ({tilde{alpha }}_{i}) in sex-i hosts, the number of mutant infections, ({tilde{I}}_{i}={tilde{I}}_{i}(t)) changes according to
$$frac{d{tilde{I}}_{f}}{dt}=frac{bv{tilde{I}}_{f}({bar{S}}_{m}+{bar{I}}_{m})}{bar{N}}+{bar{S}}_{f}beta ({tilde{alpha }}_{f}){tilde{I}}_{f}+{bar{S}}_{f}beta ({tilde{alpha }}_{m}){tilde{I}}_{m}-({gamma }_{f}+{tilde{alpha }}_{f}+mu bar{N}){tilde{I}}_{f}$$
(4a)
$$frac{d{tilde{I}}_{m}}{dt}=frac{bv{tilde{I}}_{f}({bar{S}}_{m}+{bar{I}}_{m})}{bar{N}}+{bar{S}}_{m}beta ({tilde{alpha }}_{f}){tilde{I}}_{f}+{bar{S}}_{m}beta ({tilde{alpha }}_{m}){tilde{I}}_{m}-({gamma }_{m}+{tilde{alpha }}_{m}+mu bar{N}){tilde{I}}_{m}.$$
(4b)
The system in (4) is linear and its long-term behaviour is determined by a dominant Lyapunov exponent of the mapping. We capture the information provided by the dominant Lyapunov exponent with the pathogen-fitness function, ({W}_{alpha }({tilde{alpha }}_{f},{tilde{alpha }}_{m},{alpha }_{f},{alpha }_{m})) using techniques laid out by the ref. 55 (see alsoSupplemental Information). When this function is greater than 1 the mutant invades and eventually displaces56 the resident strain associated with the i phenotype. When the function ({W}_{alpha }({tilde{alpha }}_{f},{tilde{alpha }}_{m},{alpha }_{f},{alpha }_{m})) is less than 1 the mutant does not invade and is eliminated from the population. With these facts in mind, we say that selection acts to move i in the direction given by the sign of (frac{partial {W}_{alpha }}{partial {tilde{alpha }}_{i}}{left|right.}_{tilde{alpha }=alpha }) where (tilde{alpha }=alpha) is shorthand for ({tilde{alpha }}_{i}={alpha }_{i}) for all i. Specifically, when this partial derivative is positive i is increasing, and when it is negative i is decreasing.
We follow a similar procedure for the host population by introducing, into the equilibrium population, a rare mutant-type host genotype that results in a recovery rate of ({hat{gamma }}_{i}) when expressed by sex-i hosts. We denote the numbers of susceptible and infected sex-i mutant-type hosts as ({hat{S}}_{i}) and ({hat{I}}_{i}), respectively. We assume that hosts are diploid, and so, strictly speaking, the hosts who contribute to ({hat{S}}_{i}) and ({hat{I}}_{i}) categories are heterozygotes (the numbers of homozygote mutants are negligible). While it remains rare, the dynamics of the mutant-host lineage can be described using
$$frac{d{hat{S}}_{f}}{dt}= frac{frac{b({hat{gamma }}_{f},{gamma }_{m})}{2}({hat{S}}_{f}+(1-v){hat{I}}_{f})({bar{S}}_{m}+{bar{I}}_{m})+frac{b({gamma }_{f},{hat{gamma }}_{m})}{2}({bar{S}}_{f}+(1-v){bar{I}}_{f})({hat{S}}_{m}+{hat{I}}_{m})}{bar{N}}\ +{hat{gamma }}_{f}{hat{I}}_{f}-{hat{S}}_{f}{beta }_{ff}{bar{I}}_{f}-{hat{S}}_{f}{beta }_{fm}{bar{I}}_{m}-mu bar{N}{hat{S}}_{f}$$
(5a)
$$frac{d{hat{I}}_{f}}{dt}= frac{frac{b({hat{gamma }}_{f},{gamma }_{m})}{2}v{hat{I}}_{f}({bar{S}}_{m}+{bar{I}}_{m})+frac{b({gamma }_{f},{hat{gamma }}_{m})}{2}v{bar{I}}_{f}({hat{S}}_{m}+{hat{I}}_{m})}{bar{N}}\ +{hat{S}}_{f}{beta }_{ff}{bar{I}}_{f}+{hat{S}}_{f}{beta }_{fm}{bar{I}}_{m}-({hat{gamma }}_{f}+{alpha }_{f}+mu bar{N}){hat{I}}_{f}$$
(5b)
$$frac{d{hat{S}}_{m}}{dt}= frac{frac{b({hat{gamma }}_{f},{gamma }_{m})}{2}({hat{S}}_{f}+(1-v){hat{I}}_{f})({bar{S}}_{m}+{bar{I}}_{m})+frac{b({gamma }_{f},{hat{gamma }}_{m})}{2}({bar{S}}_{f}+(1-v){bar{I}}_{f})({hat{S}}_{m}+{hat{I}}_{m})}{bar{N}}\ +{hat{gamma }}_{m}{hat{I}}_{m}-{hat{S}}_{m}{beta }_{mf}{bar{I}}_{f}-{hat{S}}_{m}{beta }_{mm}{bar{I}}_{m}-mu bar{N}{hat{S}}_{m}$$
(5c)
$$frac{d{hat{I}}_{m}}{dt}= frac{frac{b({hat{gamma }}_{f},{gamma }_{m})}{2}v{hat{I}}_{f}({bar{S}}_{m}+{bar{I}}_{m})+frac{b({gamma }_{f},{hat{gamma }}_{m})}{2}v{bar{I}}_{f}({hat{S}}_{m}+{hat{I}}_{m})}{bar{N}}\ +{hat{S}}_{m}{beta }_{mf}{bar{I}}_{f}+{hat{S}}_{m}{beta }_{mm}{bar{I}}_{m}-({hat{gamma }}_{m}+{alpha }_{m}+mu bar{N}){hat{I}}_{m}.$$
(5d)
The birth terms in the preceding system of equations reflect (a) the fact that the mutant host, while it is rare, mates only homozygous resident hosts and (b) only half of the matings between heterozygous mutants and homozygous residents result in mutant offspring. Since the dynamics described by (5) are linear, we can again measure fitness (this time for the host) using the dominant Lyapunov exponent. We summarise the relevant information contained in this exponent with the host fitness function ({W}_{gamma }({hat{gamma }}_{f},{hat{gamma }}_{m},{gamma }_{f},{gamma }_{m})), again using techniques outlined by ref. 55. In keeping with the description of pathogen evolution, we assert that the hosts i is increasing when (frac{partial {W}_{gamma }}{partial {gamma }_{i}}{left|right.}_{hat{gamma=gamma }}) is positive, and decreasing when this partial derivative is negative, where (hat{gamma }=gamma) is shorthand for ({hat{gamma }}_{i}={gamma }_{i}) for all i.
We want to identify where the action of selection takes the resident pathogen and host traits (i and i, respectively) in the long term. As mentioned above, the model is too complicated to support exact mathematical predictions. Consequently, our methods rely on numerical simulation implemented in Matlab57. All Matlab code is publicly available (see Code Availability).
The numerical simulation takes as its input a set of parameters and an initial estimate of the long-term result of selection on co-evolution of pathogen and host ({alpha }_{i}^{*}), and ({gamma }_{i}^{*}) for i=f, m. The estimate is updated by (i) finding the corresponding equilibrium solution to Equation (1) in a manner that verifies its asymptotic stability, (ii) using that equilibrium solution to estimate partial derivatives (frac{partial {W}_{alpha }}{partial {tilde{alpha }}_{i}}{left|right.}_{tilde{alpha=alpha }}) and (frac{partial {W}_{gamma }}{partial {hat{gamma }}_{i}}{left|right.}_{hat{gamma=gamma }}) for i=f, m, and finally (iii) incrementing or decrementing elements of the estimate following the sign of the appropriate partial derivative. Steps (i)(iii) are repeated until the absolute value of all partial derivatives is within a tolerance of zero. The result of the simulation is an estimate of the convergence stable58,59 co-evolutionary outcome, assuming f and m, and f and m can be adjusted independently. Importantly, this predicted co-evolutionary outcome also corresponds to a system in which the pathogen is established in a stable equilibrium population of hosts.
Finally, we verified numerically that the convergence-stable estimate corresponded to a two-dimensional evolutionarily stable result60 for pathogen and host, respectively. For this reason, we can also refer to predictions generated by our numerical simulation as a continuously stable state, in analogy to the definition established by ref. 61.
Further information on research design is available in theNature Research Reporting Summary linked to this article.
Continued here:
On maternity and the stronger immune response in women - Nature.com
- 001 Cells of the Immune System - Video [Last Updated On: October 18th, 2011] [Originally Added On: October 18th, 2011]
- 002 Can immune cells from healthy people pulverize cancer? [Last Updated On: February 4th, 2012] [Originally Added On: February 4th, 2012]
- 003 Seg_2 - Suhaasini: Immune System Boosters - 21 Feb - Suvarnanews - Video [Last Updated On: February 22nd, 2012] [Originally Added On: February 22nd, 2012]
- 004 Seg_1 - Suhaasini: Immune System Boosters - 21 Feb - Suvarnanews - Video [Last Updated On: February 22nd, 2012] [Originally Added On: February 22nd, 2012]
- 005 Researchers Find Sarcoma Tumor Immune Response With Combination Therapy [Last Updated On: March 1st, 2012] [Originally Added On: March 1st, 2012]
- 006 Transplant Procedure Creates 'Hybrid' Immune System to Combat Rejection [Last Updated On: March 8th, 2012] [Originally Added On: March 8th, 2012]
- 007 Radiation Blast May Turbocharge Bristol-Myers Melanoma Drug, Report Shows [Last Updated On: March 8th, 2012] [Originally Added On: March 8th, 2012]
- 008 Vaccination strategy may hold key to ridding HIV infection from immune system [Last Updated On: March 9th, 2012] [Originally Added On: March 9th, 2012]
- 009 Stem cell treatment tricks immune system into accepting donor organs, study shows [Last Updated On: March 9th, 2012] [Originally Added On: March 9th, 2012]
- 010 Bite-Sized Biochemistry #53 - Immune System [Last Updated On: March 9th, 2012] [Originally Added On: March 9th, 2012]
- 011 Progress, no big breakthrough, in hunt for HIV cure [Last Updated On: March 12th, 2012] [Originally Added On: March 12th, 2012]
- 012 Could the immune system help recovery from stroke? [Last Updated On: March 14th, 2012] [Originally Added On: March 14th, 2012]
- 013 'Personalized immune' mouse offers new tool for studying autoimmune diseases [Last Updated On: March 15th, 2012] [Originally Added On: March 15th, 2012]
- 014 "Personalized Immune" Mouse Offers New Tool for Studying Autoimmune Diseases Model May Allow Development of ... [Last Updated On: March 15th, 2012] [Originally Added On: March 15th, 2012]
- 015 Peoples' immune systems can now be duplicated in mice [Last Updated On: March 17th, 2012] [Originally Added On: March 17th, 2012]
- 016 Immune Role in Brain Disorder? [Last Updated On: March 19th, 2012] [Originally Added On: March 19th, 2012]
- 017 Kidney Transplant Patients Seek Life Without Immune-Suppressing Drugs [Last Updated On: March 20th, 2012] [Originally Added On: March 20th, 2012]
- 018 A Chimeric Immune System: Fixing the Problem With Organ Transplant [Last Updated On: March 20th, 2012] [Originally Added On: March 20th, 2012]
- 019 Key to immune system disease could lie inside the cheek [Last Updated On: March 21st, 2012] [Originally Added On: March 21st, 2012]
- 020 Powerful new cells cloned: Key to immune system disease could lie inside the cheek [Last Updated On: March 23rd, 2012] [Originally Added On: March 23rd, 2012]
- 021 Powerful cheek cells offer promise for combating immune system diseases [Last Updated On: March 23rd, 2012] [Originally Added On: March 23rd, 2012]
- 022 Cancer research targets a key cell protein [Last Updated On: March 27th, 2012] [Originally Added On: March 27th, 2012]
- 023 Your Gut Is Good For You: Benevolent Belly Fat Modulates Immune System, Helps Repair Tissue Damage [Last Updated On: June 7th, 2012] [Originally Added On: June 7th, 2012]
- 024 Trudeau Institute announces $9 Million Translational Research Award [Last Updated On: June 14th, 2012] [Originally Added On: June 14th, 2012]
- 025 Immune system molecule weaves cobweb-like nanonets to snag Salmonella, other intestinal microbes [Last Updated On: June 21st, 2012] [Originally Added On: June 21st, 2012]
- 026 Immune Design Corp. Announces Appointment of Dr. Roger Perlmutter as a Member of Its Board of Directors [Last Updated On: June 26th, 2012] [Originally Added On: June 26th, 2012]
- 027 Hope for Leukemia and Myelodysplasia Patients from Rabbits' Antibodies [Last Updated On: July 8th, 2012] [Originally Added On: July 8th, 2012]
- 028 Mix of Immune Cells Detects Cancer [Last Updated On: July 16th, 2012] [Originally Added On: July 16th, 2012]
- 029 New evidence links immune irregularities to autism, mouse study suggests [Last Updated On: July 18th, 2012] [Originally Added On: July 18th, 2012]
- 030 Mouse with human immune system may revolutionize HIV vaccine research [Last Updated On: July 19th, 2012] [Originally Added On: July 19th, 2012]
- 031 New Clinical Trial Seeks to Cure Advanced Crohn's Disease by Replacing a Diseased Immune System with a Healthy One [Last Updated On: July 24th, 2012] [Originally Added On: July 24th, 2012]
- 032 Clinical trial seeks to cure advanced Crohn's disease using bone marrow transplant [Last Updated On: July 24th, 2012] [Originally Added On: July 24th, 2012]
- 033 Replacing Diseased Immune System With A Healthy One To Cure Chrohn's Disease [Last Updated On: July 26th, 2012] [Originally Added On: July 26th, 2012]
- 034 Dormant HIV gets rude awakening [Last Updated On: July 28th, 2012] [Originally Added On: July 28th, 2012]
- 035 Cancer Drug Unmasks HIV in Immune Cells [Last Updated On: July 28th, 2012] [Originally Added On: July 28th, 2012]
- 036 Unexpected variation in immune genes poses difficulties for transplantation [Last Updated On: August 3rd, 2012] [Originally Added On: August 3rd, 2012]
- 037 UCLA Researchers Discover "Missing Link" Between Stem Cells and the Immune System [Last Updated On: September 1st, 2012] [Originally Added On: September 1st, 2012]
- 038 'Missing link' between stem cells and the immune system [Last Updated On: September 2nd, 2012] [Originally Added On: September 2nd, 2012]
- 039 UCLA researchers discover missing link between stem cells and immune system [Last Updated On: September 2nd, 2012] [Originally Added On: September 2nd, 2012]
- 040 'Missing link' ties blood stem cells, immune system [Last Updated On: September 6th, 2012] [Originally Added On: September 6th, 2012]
- 041 Stem Cells & Immune System: "Missing Link" Found [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- 042 Immune system molecule affects our weight [Last Updated On: September 24th, 2012] [Originally Added On: September 24th, 2012]
- 043 Immune system harnessed to improve stem cell transplant outcomes [Last Updated On: October 2nd, 2012] [Originally Added On: October 2nd, 2012]
- 044 Researchers harness the immune system to improve stem cell transplant outcomes [Last Updated On: October 2nd, 2012] [Originally Added On: October 2nd, 2012]
- 045 Vaccine to treat cervical cancer shows early promise [Last Updated On: October 11th, 2012] [Originally Added On: October 11th, 2012]
- 046 Technique shields immune system from chemo effects [Last Updated On: November 1st, 2012] [Originally Added On: November 1st, 2012]
- 047 Immunice Recommendations - Video [Last Updated On: November 9th, 2012] [Originally Added On: November 9th, 2012]
- 048 Caiden's Story - A 4-year-old's epic battle - Video [Last Updated On: November 27th, 2012] [Originally Added On: November 27th, 2012]
- 049 SU2C-CRI Cancer Immunology Translational Research Dream Team - Video [Last Updated On: December 12th, 2012] [Originally Added On: December 12th, 2012]
- 050 Immunotherapy Boosting the immune system to fight cancer - Video [Last Updated On: December 19th, 2012] [Originally Added On: December 19th, 2012]
- 051 Microgravity Affects The Immune System - The Daily Orbit - Video [Last Updated On: April 29th, 2013] [Originally Added On: April 29th, 2013]
- 052 Embryonic Stem Cells Generate Immune System - Video [Last Updated On: May 21st, 2013] [Originally Added On: May 21st, 2013]
- 053 Repairing a Damaged Immune System - Video [Last Updated On: June 28th, 2013] [Originally Added On: June 28th, 2013]
- 054 Stem Cells and the Immune System - Anastasia Filomeno - Video [Last Updated On: October 11th, 2013] [Originally Added On: October 11th, 2013]
- 055 3 - day fast might reboot your immune system - Video [Last Updated On: June 23rd, 2014] [Originally Added On: June 23rd, 2014]
- 056 WHD Murings Apak Apak Magnetic Healing Mat ( The Immune System & Stem Cell Activator ) - Video [Last Updated On: October 11th, 2014] [Originally Added On: October 11th, 2014]
- 057 A chronic lymphoblastic leukemia (CLL) patient's video diary: Immune system - Video [Last Updated On: November 22nd, 2014] [Originally Added On: November 22nd, 2014]
- 058 MS Stem Cell Medication Therapy Shows Promise - Video [Last Updated On: January 2nd, 2015] [Originally Added On: January 2nd, 2015]
- 059 Stress Weakens the Immune System [Last Updated On: May 19th, 2015] [Originally Added On: May 19th, 2015]
- 060 Your Immune System: Natural Born Killer - Crash Course ... [Last Updated On: May 19th, 2015] [Originally Added On: May 19th, 2015]
- 061 How to boost your immune system - Harvard Health [Last Updated On: May 19th, 2015] [Originally Added On: May 19th, 2015]
- 062 How Your Immune System Works - HowStuffWorks [Last Updated On: May 19th, 2015] [Originally Added On: May 19th, 2015]
- 063 Immune system - Wikipedia, the free encyclopedia [Last Updated On: May 19th, 2015] [Originally Added On: May 19th, 2015]
- 064 Immune response: MedlinePlus Medical Encyclopedia [Last Updated On: May 21st, 2015] [Originally Added On: May 21st, 2015]
- 065 Immune and Lymphatic Systems Anatomy Pictures and ... [Last Updated On: May 24th, 2015] [Originally Added On: May 24th, 2015]
- 066 Adaptive immune system - Wikipedia, the free encyclopedia [Last Updated On: May 24th, 2015] [Originally Added On: May 24th, 2015]
- 067 Immune System: Can Your Immune System ... - Biology of Aging [Last Updated On: May 29th, 2015] [Originally Added On: May 29th, 2015]
- 068 What Is the Immune System? (with pictures) [Last Updated On: June 1st, 2015] [Originally Added On: June 1st, 2015]
- 069 Immune System - KidsHealth [Last Updated On: June 3rd, 2015] [Originally Added On: June 3rd, 2015]
- 070 The Immune System | Health | Patient.co.uk [Last Updated On: June 8th, 2015] [Originally Added On: June 8th, 2015]
- 071 Immune System - Cancer Fighting Strategies [Last Updated On: June 27th, 2015] [Originally Added On: June 27th, 2015]
- 072 How Sleeping Can Affect Your Immune System - Mercola.com [Last Updated On: July 3rd, 2015] [Originally Added On: July 3rd, 2015]
- 073 14.00-Immune-Adult - Social Security Administration [Last Updated On: July 3rd, 2015] [Originally Added On: July 3rd, 2015]
- 074 Immune System: MedlinePlus - National Library of Medicine [Last Updated On: July 5th, 2015] [Originally Added On: July 5th, 2015]
- 075 Lack of Sleep and the Immune System - WebMD [Last Updated On: July 5th, 2015] [Originally Added On: July 5th, 2015]
- 076 Easy Immune System Health home page [Last Updated On: July 13th, 2015] [Originally Added On: July 13th, 2015]
- 077 Immune System News -- ScienceDaily [Last Updated On: July 24th, 2015] [Originally Added On: July 24th, 2015]
- 078 How Sleeping Can Affect Your Immune System [Last Updated On: August 5th, 2015] [Originally Added On: August 5th, 2015]
- 079 The immune system and cancer | Cancer Research UK [Last Updated On: August 19th, 2015] [Originally Added On: August 19th, 2015]
- 080 Innate immune system - Wikipedia, the free encyclopedia [Last Updated On: August 31st, 2015] [Originally Added On: August 31st, 2015]